Davis Thomas Andrew Insider Trades

Insider Trading History

Track insider trading activity for Davis Thomas Andrew. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Genocea Biosciences
Genocea Biosciences GNCA
CHIEF MEDICAL OFFICER
Holding Value $6.83 68,330 shares
Last Trade
Apr 04, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.36k 1,091 shares
$1.25
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
CHIEF MEDICAL OFFICER
Holding Value $9.38 93,750 shares
Last Trade
Mar 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$104k 93,750 shares
$1.11
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
CHIEF MEDICAL OFFICER
Holding Value $6.94 69,421 shares
Last Trade
Mar 15, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.99k 2,717 shares
$1.10
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
CHIEF MEDICAL OFFICER
Holding Value $10 100,000 shares
Last Trade
Mar 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$282k 93,750 shares
$3.01
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
CHIEF MEDICAL OFFICER
Holding Value $2.49 24,938 shares
Last Trade
Jun 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$85.8k 31,561 shares
$2.72
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
CHIEF MEDICAL OFFICER
Holding Value $4.63 46,313 shares
Last Trade
Apr 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$97.3k 58,612 shares
$1.66
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
CHIEF MEDICAL OFFICER
Holding Value $30 300,000 shares
Last Trade
Feb 07, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.3M 300,000 shares
$4.32
$0.00
Genocea Biosciences
Genocea Biosciences GNCA
CHIEF MEDICAL OFFICER
Holding Value $50 500,000 shares
Last Trade
Oct 01, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.14M 500,000 shares
$6.28
$0.00
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CMO
Holding Value $4.49M 150,000 shares
Last Trade
Jun 15, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.22M 150,000 shares
$34.80
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CMO
Holding Value $4.7M 157,000 shares
Last Trade
Jun 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.1M 157,000 shares
$70.80
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Executive VP & CMO
Holding Value $3.49M 116,500 shares
Last Trade
Jun 10, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$44.4M 116,500 shares
$381.15
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Sr. VP & CMO
Holding Value $3.49M 116,500 shares
Last Trade
Jun 04, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.5M 116,500 shares
$201.75
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Sr. VP & CMO
Holding Value $3.44M 115,000 shares
Last Trade
Jul 01, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.2M 115,000 shares
$245.40
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Sr. VP & CMO
Holding Value $3.44M 115,000 shares
Last Trade
Sep 12, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.82M 115,000 shares
$85.35
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Sr. VP & CMO
Holding Value $3.13M 104,500 shares
Last Trade
Aug 05, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.39M 104,500 shares
$42.00
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Sr. VP & CMO
Holding Value $44.6k 1,489 shares
Last Trade
Sep 16, 2010 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$141k 2,500 shares
$56.25
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Sr. VP & CMO
Holding Value $2.84M 95,000 shares
Last Trade
Jan 21, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.41M 95,000 shares
$67.50
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Sr. VP & CMO
Holding Value $2.29M 76,400 shares
Last Trade
Jan 06, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.7M 82,268 shares
$129.75
$29.93
Celldex Therapeutics
Celldex Therapeutics CLDX
Sen. VP & Ch. Medical Officer
Holding Value $0 0 shares
Last Trade
Mar 07, 2008 Sale
$93.8k 148,825 shares
$0.63
$29.93

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up